Thalya
Évry-Courcouronnes, France · Founded 2024 · $4.0M raised
- Headquarters
- Évry-Courcouronnes
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- thalya.bio
- Total Funding
- $4.0M
- Last Round
- $4.0M SeedSep 2024
- Rounds
- 1
About
Thalya is a French biotechnology company founded in August 2024 within the Entrepreneur First incubator, developing RNAi spray technology designed to improve nitrogen uptake in crops. The company's solution aims to unlock approximately $250 billion annually for farmers while reducing global greenhouse gas emissions by 4%. Thalya has signed proof-of-concept contracts covering 320 acres of land in key US corn-producing states and is backed by Y Combinator.
Summary
Thalya is a Biotech company based in Évry-Courcouronnes, France, founded in 2024. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Sep 2024. Investors include Entrepreneur First, Ring Capital and Y Combinator.
Funding History
Sep 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/thalya"><img src="https://indexed.vc/api/badge/company/thalya" alt="Thalya on Indexed.vc" width="260" height="76" /></a>